Top

ADHD Attention Deficit and Hyperactivity Disorders

Published in:

01-09-2017 | Original Article

Prevalence and correlates of ADHD in individuals with substance use disorder in Nigeria

Authors: Musa U. Umar, Auwal S. Salihu, Shakirat D. Owolabi

Published in: ADHD Attention Deficit and Hyperactivity Disorders | Issue 3/2017

Abstract

Substance use disorder (SUD) is associated with ADHD. ADHD increases the severity of SUD and has negative influence on the prognosis of the disorder. The aim of the study was to determine the prevalence and correlates of ADHD in individuals with SUD. During 2013–2015, a cross-sectional descriptive study of 233 drug treatment-seeking individuals was assessed. Diagnosis of ADHD was done using DSM-IV criteria with the Diagnostic Interview for ADHD in Adults (DIVA 2.0), while Semi-structured Assessment for Drug Dependence and Alcoholism (SSADDA 6.1) and Adult ADHD Quality of Life (AAQoL) were used for diagnosis of substance use disorder and assessment of QoL, respectively. Multivariable logistic regression was used to determine factors that were associated with ADHD. The prevalence of ADHD in SUD patients was 21.5%, with the combined subtype being the most prevalent. SUD patient with ADHD had more history of severe dependence on cigarette, depression, suicidal ideation, aggression, dependence on benzodiazepine and heroin, number of relapses, poor QoL and number of hospitalization. After logistic regression, only the number of relapses (p = 0.004), history of aggression (<0.001) and poor QoL differentiated between SUD patients with ADHD from those with no diagnosis of ADHD. The prevalence of ADHD in SUD individuals is high and may be associated with a more severe phenotypic expression of SUD.

Abdelkarim A, Salama H, Ibrahim S, Abou El Magd O (2015) The prevalence and characteristics of attention-deficit hyperactivity disorder among a sample of Egyptian substance-dependent inpatients. Egypt J Psychiatr 36(1):9–13CrossRef

Adamson TA, Ogunlesi AO, Morakinyo O, Akinhanmi AO, Onifade PO, Erinosho O, Adewuyi AA, Fasiku DA, Adebowale TO, Ogunwale A, Somoye EB, Olaniyan O (2015) Descriptive national survey of substance use in Nigeria. J Addict Res Ther 6:3. doi:10.4172/2155-6105.1000234 CrossRef

Adewuya AO, Famuyiwa OO (2007) Attention deficit hyperactivity disorder among Nigerian primary school children: prevalence and comorbid conditions. Eur Child Adolesc Psychiatr 16:10–15CrossRef

American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Publishing, ArlingtonCrossRef

Arias AJ, Gelernter J, Chan G, Weiss RD, Brady KT, Farrer L, Kranzler HR (2008) Correlates of co-occurring ADHD in drug-dependent subjects: prevalence and features of substance dependence and psychiatric disorders. Addict Behav 33:1199–1207CrossRefPubMedPubMedCentral

Barkley RA, Brown TE (2008) Unrecognized attention-deficit/hyperactivity disorder in adults presenting with other psychiatric disorders. CNS Spectr 13(11):977–984CrossRefPubMed

Brod M, Johnston J, Able S, Swindle R (2006) Validation of the adult attention-deficit/hyperactivity disorder quality-of-life scale (AAQoL): a disease-specific quality-of-life measure. Qual Life Res 15(1):117–129CrossRefPubMed

Carroll KM, Rounsaville BJ (1993) History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers. Compr Psychiatry 34(2):75–82CrossRefPubMed

Clure C, Brady KT, Saladin ME, Johnson D, Waid R, Rittenbury M (1999) Attention-deficit/hyperactivity disorder and substance use: symptom pattern and drug choice. Am J Drug Alcohol Abuse 25:441–448CrossRefPubMed

Daigre Blanco C, Ramos-Quiroga JA, Valero S, Bosch R, Roncero C, Gonzalvo B, Nogueira M (2009) Adult ADHD Self-Repoet Scale (ASRS-v1.1) symptoms checklist in patients with substance use disorders. Actas Esp Psiquiatr 37:299–305

Daigre C, Roncero C, Grau-López L, Martínez-Luna N, Prat G, Valero S, Tejedor R, Ramos-Quiroga JA, Class M (2013) Attention deficit hyperactivity disorder in cocaine-dependent adults: a psychiatric comorbidity analysis. Am J Addict 22:466–473CrossRefPubMed

De Sanctis VA, Newcorn JH, Halperin JM (2014) A prospective look at substance use and criminal behavior in urban ADHD youth: what is the role of maltreatment history on outcome? Atten Defic Hyperact Disord 6:79–86PubMed

Elkins IJ, McGue M, Iacono WG (2007) Prospective effects of attention deficit hyperactivity disorder, conduct disorder, and sex on adolescent substance use and abuse. Arch Gen Psychiatr 64(10):1145–1152CrossRefPubMed

Faraone SV, Biederman J, Mick E (2006) The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med 36(2):159–165CrossRefPubMed

Fedele DA, Lefler EK, Hartung CM, Canu WH (2012) Sex differences in the manifestation of ADHD in emerging adults. J Atten Disord 16(2):109–117CrossRefPubMed

Fergusson DM, Harwood LJ, Ridder EM (2007) Conduct and attentional problems in childhood and adolescent and later substance use, abuse and dependence: results of a 25-year longitudinal study. Drug Alcohol Depend 88(Suppl 1):S14–S26

Fossati A, Novella L, Donati D, Donini M, Maffei C (2002) History of childhood attention deficit/hyperactivity disorder symptoms and borderline personality disorder: a controlled study. Compr Psychiatr 43:369–377CrossRef

Garland AF, Hough RL, McCabe KM, Yeh M, Wood PA, Aarons GA (2001) Prevalence of psychiatric disorders in youths across five sectors of care. J Am Acad Child Adolesc Psychiatr 40:409–418CrossRef

Greenfield SF, Back SE, Lawson K, Brady KT (2010) Substance abuse in women. Psychiatr Clin North Am 33(2):339–355CrossRefPubMedPubMedCentral

Hearherton TF, Kozlowski LT, Freckner RC, Fagerström KO (1991) The Fagerström test for nicotine dependence: a revision of the Fagerström tolerance questionnaire. Brit J Addict 86:1119–1127CrossRef

Huntley Z, Maltezos S, Williams C, Morinan A, Hammon A, Ball D, Marshall EJ, Keaney F, Young S, Bolton P, Glaser K, Howe-Forbes R, Kuntsi J, Xenitidis K, Murphy D, Asherson PJ (2012) Rates of undiagnosed attention deficit hyperactivity disorder in London drug and alcohol detoxification units. BMC Psychiatr 12:223. doi:10.1186/1471-244X-12-223 CrossRef

Izutsu T, Shimotsu S, Matsumoto T, Okada T, Kikuchi A, Kojimoto M, Noguchi H, Yoshikawa K (2006) Deliberate self-harm and childhood hyperactivity in junior high school students. Eur Child Adolesc Psychiatr 15(3):172–176CrossRef

Kendler KS, Myers J (2014) The boundaries of the internalizing and externalizing genetic spectra in men and women. Psychol Med 44:647–655CrossRefPubMed

Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE (2005) Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatr 62:593–602CrossRefPubMed

Kessler RC, Adler LA, Gruber MJ, Sarawate CA, Spencer T, Van Brunt DL (2007) Validity of the World Health Organization adult ADHD self-report scale (ASRS) screener in a representative sample of health plan members. Int J Methods Psychiatr Res 16:52–65CrossRefPubMedPubMedCentral

Kirino E, Imagawa H, Goto T, Montgomery W (2015) Sociodemographics, comorbidities, healthcare utilization and work productivity in Japanese patients with adult ADHD. PLoS ONE 10(7):e0132233. doi:10.1371/journal.pone.0132233 CrossRefPubMedPubMedCentral

Kooij J, Franken M (2010) DIVA 2.0. Diagnostisch Interview Voor ADHD bij volwassenen [DIVA 2.0. Diagnostic Interview for ADHD in Adults]. Den Haag, DIVA Foundation. http://www.divacenter.eu/

Levin FR (2007) Diagnosing attention-deficit/hyperactivity disorder in patients with substance use disorders. J Clin Psychiatr 68(Suppl. 11):S9–S14

Markon KE, Krueger RF (2005) Categorical and continuous models of liability to externalizing disorders: a direct comparison in NESARC. Arch Gen Psychiatr 62:1352–1359CrossRefPubMedPubMedCentral

Mikami I, Akechi T, Kugaya A, Okuyama T, Nakano T, Okamura H, Yamawaki S, Uchitomi Y (1999) Screening of nicotine dependence among smoking-related cancer patients. Jpn J Cancer Res 90:1071–1075

Moura HF, Faller S, Benzano B, Stat D, Szobot C, Diemen L, Stolf AR, Souza-Formigoni ML, Cruz MS, Brasiliano S, Pechansky F, Kessler FH (2013) The effects of ADHD in adult substance abuse. J Addict Dis 32:252–262CrossRefPubMed

Nogueira M, Bosch R, Valero S, Gόmez-Barros N, Palomar G, Richarte V, Corrales M, Nasillo V, Vidal R, Casas M, Ramos-Quiroga JA (2014) Early-age clinical and developmental features associated to substance use disorders in attention-deficit/hyperactivity disorder in adults. Compr Psychiatr 55(3):639–649CrossRef

Ohlmeier MD, Peters K, Kordon A, Seifert J, Wildt BT, Wiese B, Ziegenbein M, Emrich HM, Schneider U (2007) Nicotine and alcohol dependence in patients with comorbid attention-deficit/hyperactivity disorder (ADHD). Alcohol Alcohol 42:539–543CrossRefPubMed

Pierucci-Lagha A, Gelernter J, Feinn R, Cubels JF, Pearson D, Farrer L, Kranzler HR (2005) Diagnostic reliability of the semi-structured assessment for drugs dependence and alcoholism (SSADDA). Drug Alcohol Depend 80(3):303–312CrossRefPubMed

Pierucci-Lagha A, Gelernter J, Chan G, Arias A, Cubels JF, Farrer L, Kranzler HR (2007) Reliabilty of DSM-Iv diagnostic criteria using the semin-structured assessment for drug dependence and alcoholism. Drug Alcohol Depend 91(1):85–90CrossRefPubMedPubMedCentral

Ramos-Quiroga JA, Nasillo V, Richarte V, Corrales M, Palma F, Ibáñez P, Michelsen M, Van de Glind G, Casas M, Kooij JJ (2016). Criteria and concurrent validity of DIVA 2.0: a semi-structured diagnostic interview for adult ADHD (2016). J Atten Disord doi:10.1177/1087054716646451

Schubiner H, Tzelepis A, Milberger S, Lockhart N, Kruger M, Kelley BJ, Schoener EP (2000) Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers. J Clin Psychiatr 61:244–251CrossRef

SimonV Czobor P, Bálint S, Mészáros A, Bitter I (2009) Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatr 194:204–211CrossRef

Soeddergaard HM, Thomsen PH, Pedersen E, Poulsen AE, Winther L, Nielsen JM, Henriksen A, Rungoe B, Soegaard HJ (2014) Associations of age, gender, and subtypes with ADHD symptoms and related comorbidity in a Danish sample of clinically referred adults. J Atten Disord. doi:10.1177/1087054713517544

Stowell RJ, Estroff TW (1992) Psychiatric disorders in substance-abusing adolescent inpatients: a pilot study. J Am Acad Child Adolesc Psychiatr 31:1036–1040CrossRef

Szobot CM, Rohde LA, Bukstein O, Molina BS, Martins C, Ruaro P, Pechansky F (2007) Is attention-deficit/hyperactivity disorder associated with illicit substance use disorders in male adolescents? A community-based case-control study. Addiction 102:1122–1130CrossRefPubMed

Umar MU, Obindo JT, Omigbodun OO (2015) Prevalence and correlates of ADHD among adolescent students in Nigeria. J Atten Disord. doi:10.1177/1087054715594456 PubMed

van de Glind G, Konstenius M, Koeter MW, van Emmerik-van Oortmerssen K, Carpentier PJ, Kaye S, Degenhardt L, Skutle A, Franck J, Bu ET, Moggi F, Dom G, Verspreet S, Demetrovics Z, Kapitány-Fövény M, Fatséas M, Auriacombe M, Schillinger A, Møller M, Johnson B, Faraone SV, Ramos-Quiroga JA, Casas M, Allsop S, Carruthers S, Schoevers RA, Wallhed S, Barta C, Alleman P, Levin FR, van den Brink W, IASP Research Group (2014) Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: results from an international multi-center study exploring DSM-IV and DSM-5 criteria. Drug Alcohol Depend. 134, 158-166

Van Emmerik-van Oortmerssen K, van de Glind G, van den Brink W, Smit F, Crunelle CL, Swets M, Schroevers RA (2012) Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis. Drug Alcohol Depend 122:11–19CrossRef

Vink JM, Willemsen G, Beem AL, Boomsma DI (2005) The Fagerström test for nicotine dependence in a Dutch sample of daily smokers and ex-smokers. Addict Behav 30:575–579CrossRefPubMed

Wilens TE (2004a) Attention-deficit/hyperactivity disorder and substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues. Psychiatr Clin North Am 27(2):283–301. doi:10.1016/S0193-953X(03)00113-8 CrossRefPubMed

Wilens TE (2004b) Impact of ADHD and its treatment on substance abuse in adults. J Clin Psychiatr 65(suppl 3):38–45

Wilens TE, Fusillo S (2007) When ADHD and substance use disorders intersect: relationship and treatment implications. Curr. Psychiatr Rep 9:408–414CrossRef

Wilens TE, Biederman J, Mick E (1998) Does ADHD affect the course of substance abuse? Findings from a sample of adults with and without ADHD. Am J Addict 7:156–163PubMed

Wilens TE, Kwon A, Tanguay S, Chase R, Moore H, Faraone SV (2005) Biederman J (2005) Characteristics of adults with attention deficit hyperactivity disorder plus substance use disorder: the role of psychiatric comorbidity. Am J Addict 14(4):319–327CrossRefPubMed

Wilens TE, Martelon M, Josh G, Bateman C, Fried R, Petty C, Biederman J (2011) Does ADHD predict substance-use disorders? A 10-year follow-up study of young adults with ADHD. J Am Acad Child Adolesc Psychiatr 50(6):543–553CrossRef

Wolke D, Woods S, Samara M (2009) Who escapes or remains a victim of bullying in primary school? Brit J Dev Psychol 27:835–851CrossRef

Title: Prevalence and correlates of ADHD in individuals with substance use disorder in Nigeria
Authors: Musa U. Umar
Auwal S. Salihu
Shakirat D. Owolabi
Publication date: 01-09-2017
Publisher: Springer Vienna
Published in: ADHD Attention Deficit and Hyperactivity Disorders / Issue 3/2017
Print ISSN: 1866-6116
Electronic ISSN: 1866-6647
DOI: https://doi.org/10.1007/s12402-017-0218-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Prevalence and correlates of ADHD in individuals with substance use disorder in Nigeria

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2017

Psychometric properties of the Japanese version of the Weiss Functional Impairment Rating Scale: Self-Report

A systematic review of circadian function, chronotype and chronotherapy in attention deficit hyperactivity disorder

Atomoxetine treatment for children and adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD): a comprehensive meta-analysis of outcomes on parent-rated core symptomatology

The development of the SGI-16: a shortened sensory gating deficit and distractibility questionnaire for adults with ADHD

Is ADHD a valid diagnosis in older adults?